This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Follow up and test of cure

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Follow-up after treatment is recommended to (1):

  • check treatment compliance
  • check whether symptoms have resolved
  • check for any adverse reactions
  • assess the risk of re-infection
  • to organise or check the progress of contact notification and provide health education

A test of cure (TOC) is recommended in all cases due to emerging resistant. In instances where TOC is required to be selective rather than universal, the following patients should be prioritized:

  • persisting symptoms or signs
  • pharyngeal infection (all treatments are less effective at eradicating pharyngeal infection)
  • treatment with anything other than the first-line recommendations (1)

If a test of cure is performed, the method and timing is arbitrary

  • persisting symptoms or signs – test with culture, performed at least 72 hours after completion of therapy
  • if asymptomatic – test with NAATs where available, followed by culture if NAAT-positive. Test two weeks after completion of antibiotic therapy (1)

Note that infection identified after treatment may well be due to reinfection (1).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.